Annual CFO
-$100.29 M
-$15.15 M-17.79%
December 31, 2023
Summary
- As of February 24, 2025, VOR annual cash flow from operations is -$100.29 million, with the most recent change of -$15.15 million (-17.79%) on December 31, 2023.
- During the last 3 years, VOR annual CFO has fallen by -$64.00 million (-176.35%).
- VOR annual CFO is now -3668.96% below its all-time high of -$2.66 million, reached on December 31, 2018.
Performance
VOR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$23.29 M
-$1.44 M-6.58%
September 30, 2024
Summary
- As of February 24, 2025, VOR quarterly cash flow from operations is -$23.29 million, with the most recent change of -$1.44 million (-6.58%) on September 30, 2024.
- Over the past year, VOR quarterly CFO has increased by +$741.00 thousand (+3.08%).
- VOR quarterly CFO is now -282.66% below its all-time high of -$6.08 million, reached on March 31, 2020.
Performance
VOR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$99.62 M
+$4.61 M+4.43%
September 30, 2024
Summary
- As of February 24, 2025, VOR TTM cash flow from operations is -$99.62 million, with the most recent change of +$4.61 million (+4.43%) on September 30, 2024.
- Over the past year, VOR TTM CFO has increased by +$669.00 thousand (+0.67%).
- VOR TTM CFO is now -1537.19% below its all-time high of -$6.08 million, reached on March 31, 2020.
Performance
VOR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VOR Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -17.8% | +3.1% | +0.7% |
3 y3 years | -176.3% | +3.1% | +0.7% |
5 y5 years | -3669.0% | +3.1% | +0.7% |
VOR Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -45.0% | at low | -32.4% | +23.6% | -44.1% | +6.5% |
5 y | 5-year | -917.7% | at low | -282.7% | +23.6% | -1537.2% | +6.5% |
alltime | all time | -3669.0% | at low | -282.7% | +23.6% | -1537.2% | +6.5% |
Vor Biopharma Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$23.29 M(+6.6%) | -$99.62 M(-4.4%) |
Jun 2024 | - | -$21.85 M(-28.3%) | -$104.24 M(-2.1%) |
Mar 2024 | - | -$30.46 M(+26.8%) | -$106.49 M(+6.2%) |
Dec 2023 | -$100.29 M(+17.8%) | -$24.03 M(-13.9%) | -$100.29 M(+6.0%) |
Sep 2023 | - | -$27.90 M(+15.8%) | -$94.61 M(+10.5%) |
Jun 2023 | - | -$24.10 M(-0.7%) | -$85.62 M(-1.0%) |
Mar 2023 | - | -$24.27 M(+32.3%) | -$86.51 M(+1.6%) |
Dec 2022 | -$85.14 M | -$18.35 M(-2.9%) | -$85.14 M(+0.9%) |
Sep 2022 | - | -$18.90 M(-24.4%) | -$84.39 M(+1.9%) |
Jun 2022 | - | -$24.99 M(+9.1%) | -$82.83 M(+11.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$22.90 M(+30.2%) | -$74.40 M(+7.6%) |
Dec 2021 | -$69.14 M(+90.5%) | -$17.59 M(+1.4%) | -$69.14 M(+6.1%) |
Sep 2021 | - | -$17.34 M(+4.7%) | -$65.19 M(+16.2%) |
Jun 2021 | - | -$16.57 M(-6.1%) | -$56.09 M(+17.2%) |
Mar 2021 | - | -$17.65 M(+29.4%) | -$47.86 M(+31.9%) |
Dec 2020 | -$36.29 M(+268.3%) | -$13.63 M(+65.4%) | -$36.29 M(+60.2%) |
Sep 2020 | - | -$8.24 M(-1.0%) | -$22.66 M(+57.2%) |
Jun 2020 | - | -$8.33 M(+36.9%) | -$14.41 M(+136.9%) |
Mar 2020 | - | -$6.08 M | -$6.08 M |
Dec 2019 | -$9.86 M(+270.3%) | - | - |
Dec 2018 | -$2.66 M | - | - |
FAQ
- What is Vor Biopharma annual cash flow from operations?
- What is the all time high annual CFO for Vor Biopharma?
- What is Vor Biopharma annual CFO year-on-year change?
- What is Vor Biopharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Vor Biopharma?
- What is Vor Biopharma quarterly CFO year-on-year change?
- What is Vor Biopharma TTM cash flow from operations?
- What is the all time high TTM CFO for Vor Biopharma?
- What is Vor Biopharma TTM CFO year-on-year change?
What is Vor Biopharma annual cash flow from operations?
The current annual CFO of VOR is -$100.29 M
What is the all time high annual CFO for Vor Biopharma?
Vor Biopharma all-time high annual cash flow from operations is -$2.66 M
What is Vor Biopharma annual CFO year-on-year change?
Over the past year, VOR annual cash flow from operations has changed by -$15.15 M (-17.79%)
What is Vor Biopharma quarterly cash flow from operations?
The current quarterly CFO of VOR is -$23.29 M
What is the all time high quarterly CFO for Vor Biopharma?
Vor Biopharma all-time high quarterly cash flow from operations is -$6.08 M
What is Vor Biopharma quarterly CFO year-on-year change?
Over the past year, VOR quarterly cash flow from operations has changed by +$741.00 K (+3.08%)
What is Vor Biopharma TTM cash flow from operations?
The current TTM CFO of VOR is -$99.62 M
What is the all time high TTM CFO for Vor Biopharma?
Vor Biopharma all-time high TTM cash flow from operations is -$6.08 M
What is Vor Biopharma TTM CFO year-on-year change?
Over the past year, VOR TTM cash flow from operations has changed by +$669.00 K (+0.67%)